Billy Wynne

Committee Approves FY 2026 Funding Bill for USDA, FDA, and Rural Development Along Party Lines

By Billy Wynne / June 25, 2025

Committee Approves FY 2026 Funding Bill for USDA, FDA, and Rural Development Along Party Lines The House Committee on Appropriations convened a markup of the Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Bill for fiscal year (FY) 2026 (text; summary; report language). A summary of key nutrition, rural development, and FDA provisions is included at…

Read More

CRS Outlines Legislative Paths for AI Regulation as Congress Considers A 10-Year Moratorium on State AI Laws

By Billy Wynne / June 24, 2025

CRS Outlines Legislative Paths for AI Regulation as Congress Considers A 10-Year Moratorium on State AI Laws The Congressional Research Service issued a report presenting Congress with a broad overview of regulatory options and policy considerations for artificial intelligence (AI). The report outlines how U.S. federal efforts have so far focused on agency-specific oversight, voluntary…

Read More

Award Terms Updated to Require Health Centers to Provide Insulin and EpiPens at or Below 340B Pricing

By Billy Wynne / June 24, 2025

Award Terms Updated to Require Health Centers to Provide Insulin and EpiPens at or Below 340B Pricing Pursuant to President Trump’s Executive Order Lowering Drug Prices by Putting Americans First, today, the Health Resources and Services Administration (HRSA) announced that it has updated its award terms to require HRSA-funded health centers to provide insulin and injectable…

Read More

Health Plans Commit to Prior Authorization Improvements; Dr. Oz and Policymakers Are Optimistic But Will Hold Plans Accountable

By Billy Wynne / June 23, 2025

Health Plans Commit to Prior Authorization Improvements; Dr. Oz and Policymakers Are Optimistic But Will Hold Plans Accountable A group of health insurance plans announced a series of voluntary commitments to simplify, reduce, and streamline prior authorization. The changes will apply across markets, including commercial coverage, Medicare Advantage, and Medicaid managed care. The Centers for Medicare and Medicaid…

Read More

2025 Marketplace Integrity and Affordability Final Rule

By Billy Wynne / June 23, 2025

2025 Marketplace Integrity and Affordability Final Rule The Centers for Medicare and Medicaid Services (CMS) issued the 2025 Marketplace Integrity and Affordability Final Rule, which includes a number of policies intended to address improper enrollments in Marketplace coverage and reduce improper federal spending on advanced premium tax credits (APTCs) (press release; fact sheet). What it…

Read More

Supreme Court Upholds Tennessee Law Banning Gender-Affirming Care for Minors; Current Policy Landscape and Implications

By Billy Wynne / June 18, 2025

Supreme Court Upholds Tennessee Law Banning Gender-Affirming Care for Minors; Current Policy Landscape and Implications Today, in a 6-3 decision on U.S. v. Skrmetti, the U.S. Supreme Court upheld Tennessee’s 2023 law (S.B. 1) banning access to gender-affirming care for minors, marking the first time the Court has ruled directly on the constitutionality of a state law targeting…

Read More

Committee Democrats Question the Process and Data Used for the MAHA Commission Report

By Billy Wynne / June 18, 2025

Committee Democrats Question the Process and Data Used for the MAHA Commission Report Senior Democrats on the House Energy & Commerce (E&C) Committee sent a letter to Secretary of the Department of Health and Human Services (HHS) Robert F. Kennedy Jr. probing about the errors that were discovered in the Make America Healthy Again (MAHA) Commission’s assessment…

Read More

Agency Launches Commissioner’s National Priority Voucher Program to Accelerate Drug Approvals Aligned with National Health Needs

By Billy Wynne / June 17, 2025

Agency Launches Commissioner’s National Priority Voucher Program to Accelerate Drug Approvals Aligned with National Health Needs The Food and Drug Administration (FDA) announced the Commissioner’s National Priority Voucher (CNPV) program, a new initiative designed to expedite the drug approval process for companies that align with U.S. national health priorities (FAQ). Unlike traditional review timelines of…

Read More

Summary of Health-Related Provisions in the FY 2025 Senate Finance Committee Reconciliation Bill Provisions

By Billy Wynne / June 16, 2025

Summary of Health-Related Provisions in the FY 2025 Senate Finance Committee Reconciliation Bill Provisions the Senate Finance Committee released its budget reconciliation text. The text primarily focuses on President Trump’s priority tax policy changes, but includes the Senate’s proposed changes to Medicaid, which largely mirror the House Reconciliation bill (press release; section-by-section; one-pager). Key Health-Related Provisions:  Includes the…

Read More

Commission June 2025 Report to Congress Addresses Certain Youth Health Care Needs and Improving Access to Medications for Opioid Use Disorder

By Billy Wynne / June 16, 2025

Commission June 2025 Report to Congress Addresses Certain Youth Health Care Needs and Improving Access to Medications for Opioid Use Disorder The Medicaid and CHIP Payment and Access Commission (MACPAC) released its March 2025 Report to Congress, with (1) transitions of care for children with special health care needs; (2) access to residential treatment for…

Read More